Literature DB >> 1324736

A single receptor identical with that from intestine/T47D cells mediates the action of 1,25-dihydroxyvitamin D-3 in HL-60 cells.

H Goto1, K S Chen, J M Prahl, H F DeLuca.   

Abstract

Two anti-vitamin D receptor monoclonal antibodies binding to two different epitopes immunoprecipitate 100% of the HL-60 1,25-dihydroxyvitamin D-3 binding activity, while another monoclonal antibody specific for the porcine receptor precipitates none. Using a rat receptor cDNA probe, a single mRNA species of 4.6 kb was detected by Northern analysis of HL-60 mRNA. Using a cDNA probe from the cloned rat receptor, 10(7) recombinants from a lambda gt11 cDNA library constructed from mRNA isolated from HL-60 cells was screened yielding two positive clones. These clones had sequences identical with the known human receptor sequence from intestinal/T47D sources. Using PCR technology, the entire sequence of the HL-60 1,25-dihydroxyvitamin D-3 receptor was determined. This sequence was found identical with that reported for the human intestinal/T47D cDNA encoding the vitamin D receptor except for a single base. The substitution of this particular base does not alter the amino acid sequence however. Thus, the same receptor likely operates in differentiation and calcium transport functions.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1324736     DOI: 10.1016/0167-4781(92)90063-6

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  3 in total

1.  Bone mineral density in relation to polymorphism at the vitamin D receptor gene locus.

Authors:  F G Hustmyer; M Peacock; S Hui; C C Johnston; J Christian
Journal:  J Clin Invest       Date:  1994-11       Impact factor: 14.808

2.  New nucleotide sequence data on the EMBL File Server.

Authors: 
Journal:  Nucleic Acids Res       Date:  1992-12-11       Impact factor: 16.971

3.  Overexpression of the vitamin D receptor (VDR) induces skeletal muscle hypertrophy.

Authors:  Joseph J Bass; Asif Nakhuda; Colleen S Deane; Matthew S Brook; Daniel J Wilkinson; Bethan E Phillips; Andrew Philp; Janelle Tarum; Fawzi Kadi; Ditte Andersen; Amadeo Muñoz Garcia; Ken Smith; Iain J Gallagher; Nathaniel J Szewczyk; Mark E Cleasby; Philip J Atherton
Journal:  Mol Metab       Date:  2020-08-07       Impact factor: 7.422

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.